Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.

Identifieur interne : 000253 ( PubMed/Corpus ); précédent : 000252; suivant : 000254

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.

Auteurs : Dariush Mozaffarian ; Roberto Marchioli ; Alejandro Macchia ; Maria G. Silletta ; Paolo Ferrazzi ; Timothy J. Gardner ; Roberto Latini ; Peter Libby ; Federico Lombardi ; Patrick T. O'Gara ; Richard L. Page ; Luigi Tavazzi ; Gianni Tognoni

Source :

RBID : pubmed:23128104

English descriptors

Abstract

Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.

DOI: 10.1001/jama.2012.28733
PubMed: 23128104

Links to Exploration step

pubmed:23128104

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</title>
<author>
<name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name>
<affiliation>
<nlm:affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name>
</author>
<author>
<name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name>
</author>
<author>
<name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name>
</author>
<author>
<name sortKey="Ferrazzi, Paolo" sort="Ferrazzi, Paolo" uniqKey="Ferrazzi P" first="Paolo" last="Ferrazzi">Paolo Ferrazzi</name>
</author>
<author>
<name sortKey="Gardner, Timothy J" sort="Gardner, Timothy J" uniqKey="Gardner T" first="Timothy J" last="Gardner">Timothy J. Gardner</name>
</author>
<author>
<name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name>
</author>
<author>
<name sortKey="Libby, Peter" sort="Libby, Peter" uniqKey="Libby P" first="Peter" last="Libby">Peter Libby</name>
</author>
<author>
<name sortKey="Lombardi, Federico" sort="Lombardi, Federico" uniqKey="Lombardi F" first="Federico" last="Lombardi">Federico Lombardi</name>
</author>
<author>
<name sortKey="O Gara, Patrick T" sort="O Gara, Patrick T" uniqKey="O Gara P" first="Patrick T" last="O'Gara">Patrick T. O'Gara</name>
</author>
<author>
<name sortKey="Page, Richard L" sort="Page, Richard L" uniqKey="Page R" first="Richard L" last="Page">Richard L. Page</name>
</author>
<author>
<name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</author>
<author>
<name sortKey="Tognoni, Gianni" sort="Tognoni, Gianni" uniqKey="Tognoni G" first="Gianni" last="Tognoni">Gianni Tognoni</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1001/jama.2012.28733</idno>
<idno type="RBID">pubmed:23128104</idno>
<idno type="pmid">23128104</idno>
<idno type="wicri:Area/PubMed/Corpus">000253</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</title>
<author>
<name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name>
<affiliation>
<nlm:affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name>
</author>
<author>
<name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name>
</author>
<author>
<name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name>
</author>
<author>
<name sortKey="Ferrazzi, Paolo" sort="Ferrazzi, Paolo" uniqKey="Ferrazzi P" first="Paolo" last="Ferrazzi">Paolo Ferrazzi</name>
</author>
<author>
<name sortKey="Gardner, Timothy J" sort="Gardner, Timothy J" uniqKey="Gardner T" first="Timothy J" last="Gardner">Timothy J. Gardner</name>
</author>
<author>
<name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name>
</author>
<author>
<name sortKey="Libby, Peter" sort="Libby, Peter" uniqKey="Libby P" first="Peter" last="Libby">Peter Libby</name>
</author>
<author>
<name sortKey="Lombardi, Federico" sort="Lombardi, Federico" uniqKey="Lombardi F" first="Federico" last="Lombardi">Federico Lombardi</name>
</author>
<author>
<name sortKey="O Gara, Patrick T" sort="O Gara, Patrick T" uniqKey="O Gara P" first="Patrick T" last="O'Gara">Patrick T. O'Gara</name>
</author>
<author>
<name sortKey="Page, Richard L" sort="Page, Richard L" uniqKey="Page R" first="Richard L" last="Page">Richard L. Page</name>
</author>
<author>
<name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</author>
<author>
<name sortKey="Tognoni, Gianni" sort="Tognoni, Gianni" uniqKey="Tognoni G" first="Gianni" last="Tognoni">Gianni Tognoni</name>
</author>
</analytic>
<series>
<title level="j">JAMA</title>
<idno type="e-ISSN">1538-3598</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Atrial Fibrillation (etiology)</term>
<term>Atrial Fibrillation (prevention & control)</term>
<term>Cardiovascular Surgical Procedures (adverse effects)</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Fatty Acids, Omega-3 (therapeutic use)</term>
<term>Female</term>
<term>Fish Oils (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Risk</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Fatty Acids, Omega-3</term>
<term>Fish Oils</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Cardiovascular Surgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Atrial Fibrillation</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Atrial Fibrillation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Dietary Supplements</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Risk</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23128104</PMID>
<DateCreated>
<Year>2012</Year>
<Month>11</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>11</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>02</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1538-3598</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>308</Volume>
<Issue>19</Issue>
<PubDate>
<Year>2012</Year>
<Month>Nov</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>JAMA</Title>
<ISOAbbreviation>JAMA</ISOAbbreviation>
</Journal>
<ArticleTitle>Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.</ArticleTitle>
<Pagination>
<MedlinePgn>2001-11</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Postoperative atrial fibrillation or flutter (AF) is one of the most common complications of cardiac surgery and significantly increases morbidity and health care utilization. A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether perioperative n-3-PUFA supplementation reduces postoperative AF.</AbstractText>
<AbstractText Label="DESIGN, SETTING, AND PATIENTS" NlmCategory="METHODS">The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) double-blind, placebo-controlled, randomized clinical trial. A total of 1516 patients scheduled for cardiac surgery in 28 centers in the United States, Italy, and Argentina were enrolled between August 2010 and June 2012. Inclusion criteria were broad; the main exclusions were regular use of fish oil or absence of sinus rhythm at enrollment.</AbstractText>
<AbstractText Label="INTERVENTION" NlmCategory="METHODS">Patients were randomized to receive fish oil (1-g capsules containing ≥840 mg n-3-PUFAs as ethyl esters) or placebo, with preoperative loading of 10 g over 3 to 5 days (or 8 g over 2 days) followed postoperatively by 2 g/d until hospital discharge or postoperative day 10, whichever came first.</AbstractText>
<AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Occurrence of postoperative AF lasting longer than 30 seconds. Secondary end points were postoperative AF lasting longer than 1 hour, resulting in symptoms, or treated with cardioversion; postoperative AF excluding atrial flutter; time to first postoperative AF; number of AF episodes per patient; hospital utilization; and major adverse cardiovascular events, 30-day mortality, bleeding, and other adverse events.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At enrollment, mean age was 64 (SD, 13) years; 72.2% of patients were men, and 51.8% had planned valvular surgery. The primary end point occurred in 233 (30.7%) patients assigned to placebo and 227 (30.0%) assigned to n-3-PUFAs (odds ratio, 0.96 [95% CI, 0.77-1.20]; P = .74). None of the secondary end points were significantly different between the placebo and fish oil groups, including postoperative AF that was sustained, symptomatic, or treated (231 [30.5%] vs 224 [29.6%], P = .70) or number of postoperative AF episodes per patient (1 episode: 156 [20.6%] vs 157 [20.7%]; 2 episodes: 59 [7.8%] vs 49 [6.5%]; ≥3 episodes: 18 [2.4%] vs 21 [2.8%]) (P = .73). Supplementation with n-3-PUFAs was generally well tolerated, with no evidence for increased risk of bleeding or serious adverse events.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this large multinational trial among patients undergoing cardiac surgery, perioperative supplementation with n-3-PUFAs, compared with placebo, did not reduce the risk of postoperative AF. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00970489.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mozaffarian</LastName>
<ForeName>Dariush</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. dmozaffa@hsph.harvard.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marchioli</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Macchia</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Silletta</LastName>
<ForeName>Maria G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gardner</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Latini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Libby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lombardi</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>O'Gara</LastName>
<ForeName>Patrick T</ForeName>
<Initials>PT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Page</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tavazzi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tognoni</LastName>
<ForeName>Gianni</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>OPERA Investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00970489</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>RC2 HL101816</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>RC2-HL101816</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA</MedlineTA>
<NlmUniqueID>7501160</NlmUniqueID>
<ISSNLinking>0098-7484</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005395">Fish Oils</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biochem. 2000 Mar;206(1-2):33-41</RefSource>
<PMID Version="1">10839192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67</RefSource>
<PMID Version="1">22051327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lipids. 2001;36 Suppl:S111-4</RefSource>
<PMID Version="1">11837983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2011 Sep 6;124(10):1100-6</RefSource>
<PMID Version="1">21844082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Cardiol. 2011 Sep 15;108(6):851-6</RefSource>
<PMID Version="1">21762871</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2012 Sep 12;308(10):1024-33</RefSource>
<PMID Version="1">22968891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Nutr. 2012 Feb;31(1):4-13</RefSource>
<PMID Version="1">22661621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Heart Rhythm. 2012 Apr;9(4):483-91</RefSource>
<PMID Version="1">22120130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2012 Mar 6;125(9):1084-93</RefSource>
<PMID Version="1">22282329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Monaldi Arch Chest Dis. 2011 Jun;76(2):93-8</RefSource>
<PMID Version="1">22128614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2002 Apr 23;105(16):1897-903</RefSource>
<PMID Version="1">11997274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Crit Care. 2002 May;11(3):228-38</RefSource>
<PMID Version="1">12022486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2003 Feb 8;361(9356):477-85</RefSource>
<PMID Version="1">12583947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2003 May;24(9):881-2</RefSource>
<PMID Version="1">12727160</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2003 Jun 3;107(21):2646-52</RefSource>
<PMID Version="1">12782616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2004 Jul 27;110(4):368-73</RefSource>
<PMID Version="1">15262826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1989 Jul 22;2(8656):177-81</RefSource>
<PMID Version="1">2568519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1989 Sep 30;2(8666):757-61</RefSource>
<PMID Version="1">2571009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb. 1991 Jul-Aug;11(4):903-11</RefSource>
<PMID Version="1">1829632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood Coagul Fibrinolysis. 1995 Feb;6(1):17-22</RefSource>
<PMID Version="1">7795149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1996 Jul 24-31;276(4):300-6</RefSource>
<PMID Version="1">8656542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13</RefSource>
<PMID Version="1">10456395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1999 Aug 7;354(9177):447-55</RefSource>
<PMID Version="1">10465168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Cardiol. 2005 May 17;45(10):1723-8</RefSource>
<PMID Version="1">15893193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chest. 2005 Aug;128(2 Suppl):9S-16S</RefSource>
<PMID Version="1">16167659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiovasc Surg (Torino). 2005 Dec;46(6):583-8</RefSource>
<PMID Version="1">16424847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2006 Oct 18;296(15):1885-99</RefSource>
<PMID Version="1">17047219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2006 Dec;27(23):2846-57</RefSource>
<PMID Version="1">17015402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2008 Oct 14;118(16):1612-8</RefSource>
<PMID Version="1">18824644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2009 Apr;30(7):820-6</RefSource>
<PMID Version="1">19196720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Thorac Cardiovasc Surg. 2009 Aug;57(5):276-80</RefSource>
<PMID Version="1">19629889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Arrhythm Electrophysiol. 2010 Feb;3(1):46-53</RefSource>
<PMID Version="1">20042769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Europace. 2010 Mar;12(3):356-63</RefSource>
<PMID Version="1">20061328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2010 Oct;31(19):2369-429</RefSource>
<PMID Version="1">20802247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2010 Dec 1;304(21):2363-72</RefSource>
<PMID Version="1">21078810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Europace. 2011 Feb;13(2):174-81</RefSource>
<PMID Version="1">21059740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am Heart J. 2011 Feb;161(2):338-343.e1</RefSource>
<PMID Version="1">21315217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Cardiol. 2011 Jan-Feb;27(1):91-7</RefSource>
<PMID Version="1">21329866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Heart Rhythm. 2011 Apr;8(4):562-8</RefSource>
<PMID Version="1">21147262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anadolu Kardiyol Derg. 2011 Jun;11(4):305-9</RefSource>
<PMID Version="1">21543294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am Heart J. 2011 Jul;162(1):56-63.e3</RefSource>
<PMID Version="1">21742090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Cardiol. 2011 Aug 15;108(4):531-5</RefSource>
<PMID Version="1">21624541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA. 2013 Mar 6;309(9):871-2</RefSource>
<PMID Version="1">23462775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA. 2013 Mar 6;309(9):871</RefSource>
<PMID Version="1">23462774</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="ErratumIn">
<RefSource>JAMA. 2013 Mar 6;309(9):876</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013504">Cardiovascular Surgical Procedures</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019587">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004311">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015525">Fatty Acids, Omega-3</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005395">Fish Oils</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012306">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS479252</OtherID>
<OtherID Source="NLM">PMC3694745</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Marchioli</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mozaffarian</LastName>
<ForeName>Dariush</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gardner</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Gara</LastName>
<ForeName>Patrick T</ForeName>
<Initials>PT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Macchia</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Santini</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tavazzi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tognoni</LastName>
<ForeName>Gianni</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Page</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lombardi</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Albert</LastName>
<ForeName>Christine M</ForeName>
<Initials>CM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maggioni</LastName>
<ForeName>Aldo P</ForeName>
<Initials>AP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Katherine T</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Latini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Libby</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Harris</LastName>
<ForeName>Bill</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saffitz</LastName>
<ForeName>Jeffery E</ForeName>
<Initials>JE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Siscovick</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stein</LastName>
<ForeName>Phyllis</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Corradi</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Masson</LastName>
<ForeName>Serge</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Nancy J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ely</LastName>
<ForeName>E Wesley</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jackson</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shintani</LastName>
<ForeName>Ayumi</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Milne</LastName>
<ForeName>Ginger L</ForeName>
<Initials>GL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Song</LastName>
<ForeName>Xiaoling</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sellke</LastName>
<ForeName>Frank W</ForeName>
<Initials>FW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Silletta</LastName>
<ForeName>Maria G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pioggiarella</LastName>
<ForeName>Raffaella</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marfisi</LastName>
<ForeName>Lorenzo</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>King</LastName>
<ForeName>Sarah L</ForeName>
<Initials>SL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mills</LastName>
<ForeName>Kristen E</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ogunleye</LastName>
<ForeName>Adeyemi</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schelling</LastName>
<ForeName>Namasha H</ForeName>
<Initials>NH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferrazzi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Simon</LastName>
<ForeName>Caterina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Iascone</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sinatra</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benedetto</LastName>
<ForeName>Umberto</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dreas</LastName>
<ForeName>Lorella</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aleksova</LastName>
<ForeName>Aneta</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rinaldi</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salizzoni</LastName>
<ForeName>Stefano</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marchetto</LastName>
<ForeName>Giovanni</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lamarra</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pagliaro</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jori</LastName>
<ForeName>Maria Cristina</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dozza</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Calvi</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Casabona</LastName>
<ForeName>Riccardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zingarelli</LastName>
<ForeName>Edoardo</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flocco</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eusebio</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raffa</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tarelli</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Parolari</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cavallotti</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Miyasoedova</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laguzzi</LastName>
<ForeName>Federica</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gregorini</LastName>
<ForeName>Renato</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mangia</LastName>
<ForeName>Federica</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gazzoli</LastName>
<ForeName>Fabrizio</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raviola</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Viganò</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Livi</LastName>
<ForeName>Ugolino</ForeName>
<Initials>U</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pompei</LastName>
<ForeName>Esmeralda</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salvador</LastName>
<ForeName>Loris</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lamascese</LastName>
<ForeName>Nicola</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bilotta</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Martinelli</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cannata</LastName>
<ForeName>Aldo</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brown</LastName>
<ForeName>Nancy J</ForeName>
<Initials>NJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Byrne</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leacche</LastName>
<ForeName>Marzia</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petracek</LastName>
<ForeName>Michael R</ForeName>
<Initials>MR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ball</LastName>
<ForeName>Stephen K</ForeName>
<Initials>SK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jessen</LastName>
<ForeName>Michael E</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Weyant</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Damiano</LastName>
<ForeName>Ralph J</ForeName>
<Initials>RJ</Initials>
<Suffix>Jr</Suffix>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sellke</LastName>
<ForeName>Frank W</ForeName>
<Initials>FW</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Arun K</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McDonald</LastName>
<ForeName>Mary Jane</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bolman</LastName>
<ForeName>R Morton</ForeName>
<Initials>R</Initials>
<Suffix>3rd</Suffix>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Conboy</LastName>
<ForeName>Debra A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Burgess</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Puskas</LastName>
<ForeName>John D</ForeName>
<Initials>JD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>VanderWoude</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<Suffix>Jr</Suffix>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bell</LastName>
<ForeName>Maria C</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sethi</LastName>
<ForeName>Gulshan</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Daniel C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Favaloro</LastName>
<ForeName>Roberto René</ForeName>
<Initials>RR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hershson</LastName>
<ForeName>Alejandro Rubén</ForeName>
<Initials>AR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Figal</LastName>
<ForeName>Julio César</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Domenech</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Halac</LastName>
<ForeName>Marcelo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nicolosi</LastName>
<ForeName>Liliana Noemí</ForeName>
<Initials>LN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morós</LastName>
<ForeName>Claudio Gabriel</ForeName>
<Initials>CG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rubio</LastName>
<ForeName>María del Carmen</ForeName>
<Initials>Mdel C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Suárez</LastName>
<ForeName>Richard Fuentes</ForeName>
<Initials>RF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cacheda</LastName>
<ForeName>Horacio</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Casal</LastName>
<ForeName>Juan Pablo</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Medrano</LastName>
<ForeName>Juan Carlos</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cucurell</LastName>
<ForeName>María Carla</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scattini</LastName>
<ForeName>Florencia</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nojek</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Camporrotondo</LastName>
<ForeName>Mariano</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mozaffarian</LastName>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Silletta</LastName>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scarano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Herrington</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brooks</LastName>
<ForeName>Maria Mori</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Caterina</LastName>
<ForeName>Raffaele</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gillinov</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Padeletti</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pellegrini</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rothschild</LastName>
<ForeName>Barbra Bluestone</ForeName>
<Initials>BB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rubinstein</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diep</LastName>
<ForeName>Pho Q</ForeName>
<Initials>PQ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guzman</LastName>
<ForeName>Junitta B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Palmarini</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sacchetti</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Flamminio</LastName>
<ForeName>Anna V</ForeName>
<Initials>AV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marfisi</LastName>
<ForeName>Rosamaria</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Scarano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Afshin</LastName>
<ForeName>Ashkan</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Hongyan</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Otite</LastName>
<ForeName>Fadar</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ambrosio</LastName>
<ForeName>Marilisa</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lincesso</LastName>
<ForeName>Annarita</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pezzoli</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anzini</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carriere</LastName>
<ForeName>Cosimo</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Belfiore</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fortunato</LastName>
<ForeName>Guglielmo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pellegrini</LastName>
<ForeName>Augusto</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raviola</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reale</LastName>
<ForeName>Vincenzo</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sorrentino</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schiavina</LastName>
<ForeName>Giulia</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Negrosanti</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ravenni</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moro</LastName>
<ForeName>Franco</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brambilla</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nava</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giroli</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Daprati</LastName>
<ForeName>Andrea</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gennari</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cusihuaman</LastName>
<ForeName>Dennis Ezra Puma</ForeName>
<Initials>DE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spagnolo</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Francia</LastName>
<ForeName>Michela</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stanca</LastName>
<ForeName>Maurizio</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paris</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Berwick</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lusona</LastName>
<ForeName>Bruno</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Castiglione</LastName>
<ForeName>Nicoletta</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De Biasio</LastName>
<ForeName>Marzia</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Daffarra</LastName>
<ForeName>Cristian</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahmad</LastName>
<ForeName>Rashid</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meisch</LastName>
<ForeName>Carol A</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maltais</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balaguer</LastName>
<ForeName>Jorge</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Donahue</LastName>
<ForeName>Tamara</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guyton</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thourani</LastName>
<ForeName>Vinod</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Halkos</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lattouf</LastName>
<ForeName>Omar</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Baio</LastName>
<ForeName>Kim T</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Levine</LastName>
<ForeName>Samatha R</ForeName>
<Initials>SR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pitts</LastName>
<ForeName>Zachary E</ForeName>
<Initials>ZE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Janssen</LastName>
<ForeName>Kathy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruhlman</LastName>
<ForeName>Marilyn</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sharp</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pang</LastName>
<ForeName>Kristy</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mungo</LastName>
<ForeName>Matías Nicolás</ForeName>
<Initials>MN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Servián</LastName>
<ForeName>Ada Liz</ForeName>
<Initials>AL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Battellini</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marenchino</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kotowicz</LastName>
<ForeName>Vadim</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cesáreo</LastName>
<ForeName>Vicente</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sánchez</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Romero</LastName>
<ForeName>Veronica</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Avila</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Donnini</LastName>
<ForeName>Fabian</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Biancospino</LastName>
<ForeName>Leticia</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laurino</LastName>
<ForeName>Romina</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Portalea</LastName>
<ForeName>Rodolfo</ForeName>
<Initials>R</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pii">1389226</ArticleId>
<ArticleId IdType="doi">10.1001/jama.2012.28733</ArticleId>
<ArticleId IdType="pubmed">23128104</ArticleId>
<ArticleId IdType="pmc">PMC3694745</ArticleId>
<ArticleId IdType="mid">NIHMS479252</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000253 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000253 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23128104
   |texte=   Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23128104" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a OperaV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Jan 4 23:09:23 2024